Metronomic scheduling of trofosfamide chemotherapy in human NSCLC xenografts highly increases therapeutic efficacy compared to conventional scheduling by inhibition of angiogenesis.

S. Stölting*, T. Klink, C. Bela, C. Engels, T. Wagner

*Corresponding author for this work
8 Citations (Scopus)
Original languageEnglish
JournalInternational journal of clinical pharmacology and therapeutics
Issue number11
Pages (from-to)652-653
Number of pages2
Publication statusPublished - 01.01.2004

Cite this